Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
ibandronate
Description:
Ibandronate is a bisphosphonate medication used to prevent and treat osteoporosis by reducing bone resorption.
Primary topic:
Bone health and treatments (39%)
Related topics:
Bone health and treatments (39%),
Bone health and osteoporosis research (38%)
Wikidata ID:
wiki/Q166825
OpenAlex ID:
keywords/ibandronate
Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy
2008
·
R. G. G. Russell
, N. B. Watts
, et al.
·
Osteoporosis International
·
1,411
Effects of Oral Ibandronate Administered Daily or Intermittently on Fracture Risk in Postmenopausal Osteoporosis
2004
·
Charles H Chesnut
, Arne Skag
, et al.
·
Journal of Bone and Mineral Research
·
1,229
PDF
Nitrogen-Containing Bisphosphonates Inhibit the Mevalonate Pathway and Prevent Post-Translational Prenylation of GTP-Binding Proteins, Including Ras
1998
·
Steven P. Luckman
, David E. Hughes
, et al.
·
Journal of Bone and Mineral Research
·
1,176
PDF
Structure-Activity Relationships for Inhibition of Farnesyl Diphosphate Synthase in Vitro and Inhibition of Bone Resorption in Vivo by Nitrogen-Containing Bisphosphonates
2001
·
James E. Dunford
, Keith Thompson
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
900
Novel insights into actions of bisphosphonates on bone: Differences in interactions with hydroxyapatite
2005
·
G.H. Nancollas
, R. Tang
, et al.
·
Bone
·
861
Bisphosphonates: from the laboratory to the clinic and back again
1999
·
R.G.G Russell
, M.J Rogers
·
Bone
·
840
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials
2015
·
†
·
The Lancet
·
754
PDF
Stimulation of γδ T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma
2000
·
Volker Kunzmann
, Eva Bauer
, et al.
·
Blood
·
669
Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases.
2000
·
S Boissier
, M Ferreras
, et al.
·
PubMed
·
572
Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats.
2002
·
Pierrick Fournier
, Sandrine Boissier
, et al.
·
PubMed
·
571
Systematic Review: Comparative Effectiveness of Treatments to Prevent Fractures in Men and Women with Low Bone Density or Osteoporosis
2008
·
Catherine MacLean
, Sydne Newberry
, et al.
·
Annals of Internal Medicine
·
530
Bisphosphonates: Mode of Action and Pharmacology
2007
·
R. Graham G. Russell
·
PEDIATRICS
·
503
Farnesyl Pyrophosphate Synthase Is the Molecular Target of Nitrogen-Containing Bisphosphonates
1999
·
Ermond van Beek
, Elsbet Pieterman
, et al.
·
Biochemical and Biophysical Research Communications
·
496
Longitudinal Cohort Study of Risk Factors in Cancer Patients of Bisphosphonate-Related Osteonecrosis of the Jaw
2009
·
Konstantinos Vahtsevanos
, Athanassios Kyrgidis
, et al.
·
Journal of Clinical Oncology
·
462
Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases
2003
·
J.-J. Body
, I.J. Diel
, et al.
·
Annals of Oncology
·
413
Bisphosphonates
2006
·
R. GRAHAM G. RUSSELL
·
Annals of the New York Academy of Sciences
·
411
The relationship between the chemistry and biological activity of the bisphosphonates
2011
·
Frank H. Ebetino
, Anne-Marie L. Hogan
, et al.
·
Bone
·
391
Bisphosphonates
2007
·
R. GRAHAM G. RUSSELL
, ZHIDAO XIA
, et al.
·
Annals of the New York Academy of Sciences
·
391
Bisphosphonates: Clinical Experience
2004
·
Robert E. Coleman
·
The Oncologist
·
384
PDF
Bisphosphonate nephrotoxicity
2008
·
Mark A. Perazella
, Glen S. Markowitz
·
Kidney International
·
363
Protein Geranylgeranylation Is Required for Osteoclast Formation, Function, and Survival: Inhibition by Bisphosphonates and GGTI-298
2000
·
Fraser P. Dr. Coxon
, Miep H. Helfrich
, et al.
·
Journal of Bone and Mineral Research
·
361
PDF
Bisphosphonates for breast cancer
2002
·
N Pavlakis
, M Stockler
·
360
Bisphosphonates inhibit prostate and breast carcinoma cell adhesion to unmineralized and mineralized bone extracellular matrices.
1997
·
S Boissier
, S Magnetto
, et al.
·
PubMed
·
347
Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid.
2006
·
Meletios A Dimopoulos
, Efstathios Kastritis
, et al.
·
PubMed
·
340
Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies
2004
·
J J Body
, I J Diel
, et al.
·
British Journal of Cancer
·
336
PDF
Show more works
View as search
Works count:
2,801
Citation count:
56,690
Year
Topic
Type
